NIAID Site Search

Proposals are accepted either as Collaborative Study projects or as Technology Development/enhancement projects. Collaborative studies aim to leverage cutting-edge technologies and expertise currently available in the CHI to enable systems-level characterization of immune phenotypes.

Last Reviewed: April 10, 2025

Information for NIAID researchers outlining the procedure for submitting a grant application.

Last Reviewed: June 3, 2021

National Institutes of Health // Food and Drug Administration // Immunology Interest Group

Last Reviewed: October 6, 2022

Jordan Report: Accelerated Development of Vaccines (2007) from NIAID includes updates on vaccine research for specific infectious diseases.

Last Reviewed: August 6, 2019

Jordan Report: Accelerated Development of Vaccines (2002) from NIAID includes updates on vaccine research for specific infectious diseases.

Last Reviewed: December 31, 2002

LMIV Vaccine Development Unit develops and performs clinical evaluation of prototype malaria vaccines. The VDU focuses on research to eradicate malaria through development of a vaccine to interrupt malaria transmission, including transmission-blocking components and pre-erythrocytic components. The VDU also designs and develops vaccines specifically to protect pregnant women and their infants.

Last Reviewed: November 21, 2022